Aldesleukin Completed Phase 1 Trials for Multiple Myeloma and Plasma Cell Neoplasm / Malignant Lymphomas / Leukemias Treatment

CompletedTreatment1 IdentifierTitleDrugs
NCT00003962Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00012207Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00009698Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
NCT00182650Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
NCT00058045Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer
NCT00020462Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
NCT00002687Interleukin-2 in Treating Patients With Mycosis Fungoides